Preparation and characterization of adefovir dipivoxil–stearic acid cocrystal with enhanced physicochemical properties

References

• Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, Ahmad FJ, Talegaonkar S. 2011. The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opin Ther Pat. 21:561–576.
   PubMed Web of Science ®Google Scholar
• Annaert P, Van Gelder J, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P. 1998. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers. Pharm Res. 15:1168–1173.
   PubMed Web of Science ®Google Scholar
• Antikainen O, Yliruusi J. 2003. Determining the compression behaviour of pharmaceutical powders from the force-distance compression profile. Int J Pharm. 252:253–261.
   PubMed Web of Science ®Google Scholar
• Basavoju S, Boström D, Velaga SP. 2006. Pharmaceutical cocrystal and salts of norfloxacin. Cryst Growth Des. 6:2699–2708.
   Web of Science ®Google Scholar
• Blagden N, de Matas M, Gavan PT, York P. 2007. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 59:617–630.
   PubMed Web of Science ®Google Scholar
• Brittain HG. 2013. Pharmaceutical cocrystals: the coming wave of new drug substances. J Pharm Sci. 102:311–317.
   PubMed Web of Science ®Google Scholar
• Chattoraj S, Shi L, Sun CC. 2010. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1:1 co-crystal. CrystEngComm. 12:2466–2472.
   Web of Science ®Google Scholar
• Chow SF, Chen M, Shi L, Chow AHL, Sun CC. 2012. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 29:1854–1865.
   PubMed Web of Science ®Google Scholar
• Chun N-H, Wang I-C, Lee M-J, Jung Y-T, Lee S, Kim W-S, Choi GJ. 2013. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process. Eur J Pharm Biopharm. 85:854–861.
   PubMed Web of Science ®Google Scholar
• Di Martino P, Beccerica M, Joiris E, Palmieri GF, Gayot A, Martelli S. 2002. Influence of crystal habit on the compression and densification mechanism of ibuprofen. J Cryst Growth. 243:345–355.
   Web of Science ®Google Scholar
• Dodiya S, Chavhan S, Korde A, Sawant KK. 2013. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies. Drug Dev Ind Pharm. 39:733–743.
   PubMed Web of Science ®Google Scholar
• Elder DP, Holm R, Diego HLd. 2013. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Int J Pharm. 453:88–100.
   PubMed Web of Science ®Google Scholar
• Freeman R. 2007. Measuring the flow properties of consolidated, conditioned and aerated powders - a comparative study using a powder rheometer and a rotational shear cell. Powder Technol. 174:25–33.
   Web of Science ®Google Scholar
• Gao Y, Gao J, Liu Z, Kan H, Zu H, Sun W, Zhang J, Qian S. 2012. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals. Int J Pharm. 438:327–335.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zu H, Zhang J. 2011. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation. J Pharm Pharmacol. 63:483–490.
   PubMed Web of Science ®Google Scholar
• Gupta S, Chavhan S, Sawant KK. 2011. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A. 392:145–155.
   Web of Science ®Google Scholar
• Heckel R. 1961. Density-pressure relationships in powder compaction. Trans Metall Soc AIME. 221:671–675.
   Google Scholar
• Hiendrawan S, Veriansyah B, Widjojokusumo E, Soewandhi SN, Wikarsa S, Tjandrawinata RR. 2016. Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid. Int J Pharm. 497:106–113.
   PubMed Web of Science ®Google Scholar
• Ho R, Naderi M, Heng JY, Williams D, Thielmann F, Bouza P, Keith A, Thiele G, Burnett D. 2012. Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals. Pharm Res. 29:2806–2816.
   PubMed Web of Science ®Google Scholar
• Ilkka J, Paronen P. 1993. Prediction of the compression behaviour of powder mixtures by the Heckel equation. Int J Pharm. 94:181–187.
   Web of Science ®Google Scholar
• Jallo LJ, Ghoroi C, Gurumurthy L, Patel U, Davé RN. 2012. Improvement of flow and bulk density of pharmaceutical powders using surface modification. Int J Pharm. 423:213–225.
   PubMed Web of Science ®Google Scholar
• Jung S, Lee J, Kim IW. 2013. Structures and physical properties of the cocrystals of adefovir dipivoxil with dicarboxylic acids. J Cryst Growth. 373:59–63.
   Web of Science ®Google Scholar
• Khomane K, Bansal A. 2013. Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs. AAPS PharmSciTech. 14:1169–1177.
   PubMed Web of Science ®Google Scholar
• Khomane KS, More PK, Bansal AK. 2012. Counterintuitive compaction behavior of clopidogrel bisulfate polymorphs. J Pharm Sci. 101:2408–2416.
   PubMed Web of Science ®Google Scholar
• Ku MS, Dulin W. 2012. A biopharmaceutical classification-based right-first-time formulation approach to reduce human pharmacokinetic variability and project cycle time from first-in-human to clinical proof-of-concept. Pharm Dev Technol. 17:285–302.
   PubMed Web of Science ®Google Scholar
• Liu M, Hong C, Yao Y, Shen H, Ji G, Li G, Xie Y. 2016. Development of a pharmaceutical cocrystal with solution crystallization technology: preparation, characterization, and evaluation of myricetin-proline cocrystals. Eur J Pharm Biopharm. 107:151–159.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X, Pan W. 2012. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 13:295–304.
   PubMed Web of Science ®Google Scholar
• Ma K, Zhang Y, Kan H, Cheng L, Luo L, Su Q, Gao J, Gao Y, Zhang J. 2014. Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization. Pharm Res. 31:1766–1778.
   PubMed Web of Science ®Google Scholar
• Marcellin P, Chang T-T, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, et al. 2003. Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B. N Engl J Med. 348:808–816.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Bolourtchian N, Dinarvand R. 2003. Crystal modification of phenytoin using different solvents and crystallization conditions. Int J Pharm. 250:85–97.
   PubMed Web of Science ®Google Scholar
• Nordström FL, Rasmuson ÅC. 2009. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds. Eur J Pharm Sci. 36:330–344.
   PubMed Web of Science ®Google Scholar
• Ober CA, Montgomery SE, Gupta RB. 2013. Formation of itraconazole/L-malic acid cocrystals by gas antisolvent cocrystallization. Powder Technol. 236:122–131.
   Web of Science ®Google Scholar
• Rahman Z, Agarabi C, Zidan AS, Khan SR, Khan MA. 2011. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide. AAPS PharmSciTech. 12:693–704.
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM. 2007. Lipid excipients peceol and gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci. 10:319–331.
   PubMed Web of Science ®Google Scholar
• Schultheiss N, Newman A. 2009. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 9:2950–2967.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 59:603–616.
   PubMed Web of Science ®Google Scholar
• Severino P, Pinho SC, Souto EB, Santana MHA. 2011. Polymorphism, crystallinity and hydrophilic–lipophilic balance of stearic acid and stearic acid–capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B: Biointerfaces. 86:125–130.
   PubMed Web of Science ®Google Scholar
• Soares FLF, Carneiro RL. 2014. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals. J Pharm Biomed Anal. 89:166–175.
   PubMed Web of Science ®Google Scholar
• Stanton MK, Bak A. 2008. Physicochemical properties of pharmaceutical co-crystals: a case study of ten AMG 517 co-crystals. Cryst Growth Des. 8:3856–3862.
   Web of Science ®Google Scholar
• Steed JW. 2013. The role of co-crystals in pharmaceutical design. Trends Pharmacol Sci. 34:185–193.
   PubMed Web of Science ®Google Scholar
• Stella VJ, Nti-Addae KW. 2007. Prodrug strategies to overcome poor water solubility. Adv Drug Deliv Rev. 59:677–694.
   PubMed Web of Science ®Google Scholar
• Sun CC, Hou H. 2008. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des. 8:1575–1579.
   Web of Science ®Google Scholar
• Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodríguez-Hornedo N. 2013. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 453:101–125.
   PubMed Web of Science ®Google Scholar
• van Hoogevest P, Liu X, Fahr A. 2011. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective. Expert Opin Drug Deliv. 8:1481–1500.
   PubMed Web of Science ®Google Scholar
• Vippagunta SR, Wang Z, Hornung S, Krill SL. 2007. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci. 96:294–304.
   PubMed Web of Science ®Google Scholar
• Wu Y, Loper A, Landis E, Hettrick L, Novak L, Lynn K, Chen C, Thompson K, Higgins R, Batra U, et al. 2004. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int J Pharm. 285:135–146.
   PubMed Web of Science ®Google Scholar
• Yan Y, Chen J-M, Lu T-B. 2013. Simultaneously enhancing the solubility and permeability of acyclovir by crystal engineering approach. CrystEngComm. 15:6457–6460.
   Web of Science ®Google Scholar
• Yuan L-C, Dahl T, Oliyai R. 2000. Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil. Pharm Res. 17:1098–1103.
   PubMed Web of Science ®Google Scholar